Search alternatives:
significant risks » significant risk (Expand Search), significant results (Expand Search), significant role (Expand Search)
point decrease » point increase (Expand Search)
risks decrease » sizes decrease (Expand Search), visits decreased (Expand Search), rivers decreased (Expand Search)
significant risks » significant risk (Expand Search), significant results (Expand Search), significant role (Expand Search)
point decrease » point increase (Expand Search)
risks decrease » sizes decrease (Expand Search), visits decreased (Expand Search), rivers decreased (Expand Search)
-
1
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
2
-
3
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
4
-
5
-
6
-
7
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
8
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
9
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
10
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
11
-
12
-
13
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
14
-
15
-
16
-
17
HFD decreases intermediate-term memory.
Published 2025“…<p>(A) The survival rate of 10d <i>Canton-S</i> fed with ND or HFD was observed for 7 days. There was no significant decline in the survival rate in flies fed with HFD compared with ND (n = 10 vials, containing 20 flies at each time point). …”
-
18
-
19
-
20